Other News To Note
• An in vivo study by Biothera Inc., of Eagan, Minn., showed that Imprime PGG enhances the antitumor function of immune cells and directs a percentage of them to the tumor microenvironment. Imprime PGG is designed as an immunomodulator and is being developed for chronic lymphocytic leukemia and non-Hodgkin lymphoma.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter